Understanding Heart Disease Caused by Amyloid Protein Buildup

This is a registry study — not a test of new medication, but rather a careful collection of medical information from patients who already have cardiac amyloidosis (a condition where an abnormal protein called amyloid builds up in the heart). Researchers at University Hospital Leipzig want to gather detailed information about your heart health, test results, imaging scans, and quality of life over time to better understand how this disease affects patients in real clinical practice.

While large research trials have shown warning signs and new treatments for cardiac amyloidosis, those studies often include only very selected patients and may not reflect what actually happens in everyday hospital care across different countries and patient populations. This registry aims to fill that gap by collecting real-world data about how the disease progresses, what happens when doctors use different diagnostic methods, and how comorbidities (other health conditions) affect patients' outcomes.